我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。
开放获取期刊获得更多读者和引用 700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
研究文章
Safety and Effectiveness of Xofluza (Baloxavir Marboxil) for Respiratory Viral Illness: A Systematic Review
社论
Young Researchers Forum - Young Scientist Awards at 4th Global Congress on Bacteriology and Infectious Diseases
Presenting Characteristics and ICU Admission among Patients Hospitalized with COVID-19
案例报告
Recurrence or Relapse of COVID 19 Infection
Covid-19. A review in Covid-19 Infections and Treatment Through Understanding Viral First Main Steps in Respiratory Cells
简短的沟通
Opportunistic Pathogens Can Cause an Infectious Disease in a Host With Depressed Resistance